Abdominal cocoon syndrome is a condition in which a fibrocollagenous membrane gradually encases loops of the small bowel, constricting them into a clustered mass that behaves like a mechanical bottleneck for digestion. The result is recurrent or complete small bowel obstruction, one of the most common surgical emergencies encountered worldwide. Obstruction of the small intestine is usually caused by postoperative adhesions, hernias, malignancy, or inflammatory bowel disease, but cocoon syndrome stands apart because it can strike patients who have never had abdominal surgery, a detail that makes clinicians far less likely to suspect it. The syndrome was first described in the medical literature in 1978, and its etiology remains poorly understood, though an inflammatory cascade is thought to stimulate fibroblast proliferation and collagen deposition, eventually producing the dense encapsulating layer that gives the disease its name.

The Tunisian patient’s history was notable precisely for its emptiness. He denied any prior abdominal surgery, peritoneal dialysis, abdominal trauma, appendicitis, gastrointestinal perforation, foreign-body ingestion, peptic ulcer disease, or inflammatory bowel disease. He took no chronic medications, including corticosteroids, nonsteroidal anti-inflammatory drugs, or opioids, and had no diabetes, hypertension, or autoimmune disorders. His family history was unremarkable for gastrointestinal disease or tuberculosis. On admission he appeared mildly dehydrated, with a distended, tympanic abdomen and diffuse tenderness but no signs of peritonitis. Laboratory tests showed mild leukocytosis of 13,000 cells per cubic millimeter, with otherwise normal electrolytes and inflammatory markers. Abdominal radiography revealed multiple air-fluid levels consistent with partial small bowel obstruction, prompting further imaging.

Contrast-enhanced computed tomography proved decisive. The scan demonstrated hydro-aeric distension of intestinal loops up to 57 millimeters in diameter, with progressive tapering in the right iliac fossa and moderate free fluid in the pelvis and left paracolic gutter. The characteristic finding, described in the literature as the cauliflower or cocoon sign, is a cluster of small bowel loops surrounded by a fibrotic sac, and the authors note that contrast-enhanced CT is considered the imaging modality of choice because of its ability to demonstrate this pattern. Even so, the diagnosis can remain elusive. Many cases in the published literature, including several in the review accompanying this report, were confirmed only during surgery, because the radiologic features are nonspecific and the syndrome itself is so rare that few radiologists or surgeons encounter it more than once in a career.

The patient was initially managed conservatively with nasogastric decompression, fluid resuscitation, and correction of electrolyte imbalance, a standard first-line approach for partial bowel obstruction. But his obstructive symptoms persisted after 48 hours, and the surgical team decided that exploratory laparotomy was indicated. Inside the abdomen, they found the small intestine encased within a dense, whitish fibrous membrane forming a cocoon-like sac. There was no mesenteric lymphadenopathy, no caseous nodules, and no purulent fluid, findings that helped argue against an infectious cause. The surgeons performed careful adhesiolysis, the deliberate freeing of adhesions, and total excision of the fibrotic capsule without bowel resection, because all loops were viable and regained peristalsis after release. Peritoneal fluid and membrane biopsies were sent for microbiological and histopathological evaluation, including acid-fast bacillus staining, culture, and adenosine deaminase assay, all of which came back negative for tuberculosis.

That tuberculosis work-up was not a formality. Secondary forms of abdominal cocoon syndrome are associated with peritoneal dialysis, tuberculosis, autoimmune diseases, and chronic infections, and the authors emphasize that clinicians evaluating recurrent small bowel obstruction should actively exclude tuberculous peritonitis, which can closely mimic the idiopathic form. They recommend a detailed tuberculosis history, chest imaging, and, when suspicion exists, targeted investigations such as ascitic or peritoneal fluid acid-fast bacillus smear, adenosine deaminase assay, culture, and molecular testing with CB-NAAT or GeneXpert. During surgery, representative peritoneal biopsy and fluid sampling for histopathology and microbiology are strongly recommended, because macroscopic appearance alone may not reliably exclude tuberculosis. In this case, histopathologic examination confirmed fibrocollagenous tissue without granulomatous inflammation, supporting an idiopathic diagnosis.

The postoperative course was swift. The patient was monitored for the return of bowel function, abdominal distension, and signs of infection, and oral intake resumed on postoperative day two after the passage of flatus. He received prophylactic antibiotics, ceftriaxone combined with metronidazole for 48 hours, along with analgesia, and was discharged on postoperative day four with normal bowel transit. At follow-up visits at two and six weeks he remained asymptomatic, and he expressed satisfaction with the outcome while providing written consent for publication of his clinical details and images. The authors report that early operative management of this syndrome generally results in excellent postoperative recovery and minimal recurrence, and their patient’s trajectory illustrates that point in practice.

To place the case in context, the team reviewed English-language literature on abdominal cocoon syndrome published between January 2015 and June 2024, searching PubMed and Google Scholar and including only single case reports and small case series with sufficient clinical detail. The synthesis, spanning cases from Pakistan, the United Kingdom, China, Greece, Egypt, Saudi Arabia, Iraq, Turkey, Kuwait, Morocco, India, Thailand, and Ethiopia, highlights that the syndrome predominantly affects young to middle-aged males from tropical and subtropical regions. Yet the collected cases also show the disease’s range of severity: some patients presented with straightforward obstruction, while others arrived with bowel perforation, internal fistulas, ischemic segments, or extensive small bowel necrosis. In a Thai series of three patients, one died, underscoring that delays in diagnosis can carry fatal consequences. Notably, the review also documents that idiopathic forms in middle-aged and older adults, like the Tunisian patient, are increasingly reported, even though the classic textbook portrait involves younger men.

Treatment remains an area of active debate. In early stages or in cases with intermittent symptoms, conservative management with bowel rest, hydration, nutritional support, and nasogastric decompression may be attempted. But when obstruction is complete or conservative measures fail, surgery is mandated, and the definitive procedure involves adhesiolysis and careful removal of the fibrous membrane encasing the intestine. There is growing interest in laparoscopic approaches, which offer reduced postoperative pain, faster recovery, and shorter hospital stays, and one case in the review achieved an excellent outcome with laparoscopic adhesiolysis. However, minimally invasive management is technically challenging because of dense adhesions and the risk of bowel injury, so case selection is crucial and conversion to open surgery may be required if safe dissection cannot be ensured. In the present case, the authors considered laparoscopy but deferred it because marked intestinal distension and dense adhesions on imaging made open laparotomy the safer approach. In patients with advanced liver cirrhosis or other comorbid conditions, perioperative morbidity is significantly heightened and approaches must be tailored accordingly.

The authors acknowledge the limits of the evidence base. No definitive pathophysiologic mechanism or molecular biomarker exists to distinguish idiopathic from secondary forms before surgery, CT sensitivity for early or partial disease is limited, and because the condition is so rare, treatment algorithms are largely derived from isolated case reports rather than comparative studies. Recurrence is exceptional but may occur when fibrotic tissue excision is incomplete or persistent inflammation promotes re-encapsulation, so the team advises structured follow-up with clinical evaluation at three and twelve months and abdominal imaging if symptoms return. Medical therapies aimed at modulating peritoneal fibrosis, including short courses of corticosteroids or tamoxifen, have been reported anecdotally but require validation, and the authors call for future multicenter registries to define optimal surveillance intervals and identify predictive factors for recurrence. Their central message for clinicians is straightforward: abdominal cocoon syndrome deserves a place on the differential diagnosis for any patient with recurrent or unexplained small bowel obstruction, especially those who have never undergone abdominal surgery, because timely recognition, careful bowel-preserving membrane excision, and structured postoperative monitoring can convert a potentially dangerous condition into one with an excellent outcome.

Subject of Research: Abdominal cocoon syndrome as a rare cause of small bowel obstruction

Article Title: Small bowel obstruction secondary to abdominal cocoon syndrome: Case report and review of the literature

Article References: Ben Ismail, I., Sghaier, M., Amari, R., Yaakoubi, J., Zenaidi, H., & Zoghlami, A. (2026). Small bowel obstruction secondary to abdominal cocoon syndrome: Case report and review of the literature. Heliyon, 12(15), Article e45437. https://doi.org/10.1016/j.heliyon.2026.e45437

Image Credits: AI Generated

DOI: 10.1016/j.heliyon.2026.e45437

Keywords: abdominal cocoon syndrome, sclerosing encapsulating peritonitis, small bowel obstruction, case report, computed tomography, adhesiolysis, fibrous membrane, tuberculosis, general surgery, Heliyon, idiopathic peritoneal sclerosis, laparotomy

Small bowel obstruction is far from a niche problem. Postoperative adhesions account for an estimated 12 to 16 percent of surgical admissions in the United States, and comparable burdens have been documented in Swedish and Korean registry data. Management is frequently prolonged, may require reoperation or extensive bowel resection, and carries an operative mortality approaching 5 percent, alongside impaired nutrition and reduced quality of life for survivors. Despite this clinical and economic toll, standardized prevention strategies remain elusive, and current practice depends largely on surgeon preference rather than high-quality evidence.

The biological logic behind the new findings is straightforward. Postoperative obstruction arises primarily when the parietal and visceral peritoneum, the slippery membranes lining the abdominal cavity and covering the organs, are damaged during surgery, prompting scar tissue formation. Laparoscopic surgery, performed through small incisions with camera guidance, minimizes peritoneal trauma. Adhesion prevention materials, such as the hyaluronic acid-carboxymethylcellulose film Seprafilm, act as physical barriers between injured peritoneal surfaces during healing. Yet randomized trials, including the influential COLOR II trial of rectal cancer, had failed to show that laparoscopy significantly reduces obstruction, partly because laparoscopy reduces parietal adhesions more effectively than visceral ones.

To resolve these uncertainties, the researchers drew on a nationwide retrospective survey covering 18,798 gastrointestinal surgeries across 32 institutions, of which 5811 involved colorectal disease. After excluding benign conditions and incomplete records, 5458 patients with histologically confirmed colorectal cancer remained. Of these, 3193 patients, or 58.5 percent, underwent laparoscopic surgery, while 2265, or 41.5 percent, had open operations. Over five years of follow-up, 283 cases of small bowel obstruction were identified, defined as clinically diagnosed obstruction requiring hospitalization and fasting for more than one day, with suspected cancer recurrences excluded.

Because patients were treated at many different hospitals, the team used mixed-effects logistic regression with hospital as a random intercept, a statistical technique that accounts for institutional clustering and prevents any single center from distorting the results. The model adjusted for age, sex, tumor location, and stoma creation. The headline result was striking: laparoscopic surgery was independently associated with a 42 percent reduction in the odds of developing obstruction compared with open surgery, with an adjusted odds ratio of 0.58 and a confidence interval of 0.45 to 0.74, highly statistically significant. In absolute terms, the risk fell from 6.8 percent with open surgery to 4.1 percent with laparoscopy, an absolute risk reduction of 2.7 percent, equivalent to a number needed to treat of 37.

That last figure deserves unpacking for readers unfamiliar with clinical epidemiology. A number needed to treat of 37 means that for every 37 patients shifted from open to laparoscopic surgery, one case of small bowel obstruction would be prevented over five years. The benefit, however, was not uniform across the bowel. Site-specific analyses revealed statistically significant reductions in ascending colon surgery, where the number needed to treat dropped to 22.2, and in sigmoid colon surgery, at 30.2. No significant reduction was seen in the cecum, transverse colon, descending colon, or rectum. The transverse colon, highly mobile and often requiring omental dissection, may blunt laparoscopy’s advantage, while rectal surgery involves deep pelvic dissection, frequent stomas, and possible neoadjuvant radiotherapy, all of which complicate the picture.

In contrast to the laparoscopy findings, adhesion prevention materials were a clear null result. Seprafilm, the only such product approved for gastrointestinal surgery in Japan during the study period, showed no significant association with reduced obstruction, with an adjusted odds ratio of 1.01 and a p-value of 0.94. When patients were stratified by surgical approach, obstruction rates were nearly identical with and without the film in both laparoscopic and open groups. Usage varied dramatically across hospitals, from 0 to 99.2 percent, and surgeons applied it at their own discretion, raising the possibility of confounding by indication, in which the film was preferentially used in the most complex, highest-risk operations, potentially masking a genuine benefit. Still, the findings echo a randomized trial that likewise found no significant obstruction reduction with the material in colorectal cancer patients.

Perhaps the most clinically provocative finding concerned stomas. Patients who received a stoma, a surgical opening of the bowel through the abdominal wall, faced an 84 percent increase in the odds of obstruction, with an odds ratio of 1.84. Among rectal cancer patients, 11.4 percent of those with stomas developed obstruction versus 5.1 percent of those without. Notably, the risk was similar for ileostomies, at 13.2 percent, and colostomies, at 10.6 percent, suggesting that the presence of a stoma itself, rather than its type or fluid output, is the key driver. The mechanism likely involves both additional peritoneal trauma from stoma creation and closure and non-adhesive problems such as kinking at the abdominal wall passage or parastomal hernia. The authors argue that stoma creation warrants judicious use, reserved for cases where the danger of anastomotic leakage clearly outweighs the obstruction risk.

Tumor location emerged as an independent determinant in its own right. Rectal cancer carried the highest obstruction incidence at 6.8 percent, and all colonic sites except the descending colon showed significantly lower odds than the rectum. This pattern reflects surgical anatomy: total mesorectal excision in the confined pelvic space, often combined with radiotherapy and stomas, promotes adhesion formation, while descending colon resections demand splenic flexure mobilization and extended dissection. Sigmoid colon surgery, despite its anatomical proximity to the rectum, enjoyed lower risk, plausibly because of more straightforward operative planes and fewer stomas.

The study’s statistical rigor extended to sensitivity analyses. E-value calculations, which estimate how strong an unmeasured confounder would need to be to erase the observed associations, reached 2.84 for laparoscopic surgery and 3.08 for stoma creation, indicating reasonably robust findings, while the E-value of 1.11 for adhesion films was consistent with a true null effect. Nonetheless, the authors are candid about limitations. The retrospective, non-randomized design cannot prove causation, and variables such as body mass index, tumor stage, diabetes, neoadjuvant therapy, prior abdominal surgery, and emergency operations were unavailable. Because factors like advanced stage and obesity push surgeons toward open surgery while independently raising adhesion risk, confounding, if present, would tend to overstate laparoscopy’s protective effect, not undermine it. The binary five-year endpoint also prevented time-to-event analysis, could not distinguish early from late obstruction, and did not capture obstruction severity or episodes occurring decades later.

Even with those caveats, the study’s implications are substantial. It suggests that the benefits of minimally invasive colorectal cancer surgery extend beyond the well-established short-term advantages of less pain and faster recovery into meaningful long-term protection against bowel obstruction, particularly in ascending and sigmoid colon resections. It casts serious doubt on the routine use of adhesion barrier films under current, unstandardized practice patterns, and it flags stoma creation as a modifiable risk factor deserving careful weighing. As robotic platforms, refined laparoscopic techniques, and enhanced recovery protocols spread, the balance of risks may shift further, and the authors call for prospective studies with time-to-event data reflecting contemporary practice. For now, the message to surgical teams is clear: the route taken through the abdominal wall may echo in a patient’s health for years to come.

Subject of Research: The association of laparoscopic surgery, adhesion prevention materials, and stoma creation with five-year small bowel obstruction risk after colorectal cancer surgery.

Article Title: Laparoscopic Surgery Is Associated With Reduced Small Bowel Obstruction Risk After Colorectal Cancer Surgery: A Nationwide Cohort Study of 5458 Patients

Article References: Yamada, T., Fujita, F., Eto, K., Kataoka, K., Yukawa, N., Sugimoto, K., Shimoyama, R., Fukazawa, A., Kumamoto, K., Takayama, Y., Komono, A., Matsuda, A., Ohta, R., Sonoda, H., Okuya, K., Ihara, K., Yokoyama, Y., Nishino, T., Akiyama, Y., & Ichikawa, D. (2026). Laparoscopic Surgery Is Associated With Reduced Small Bowel Obstruction Risk After Colorectal Cancer Surgery: A Nationwide Cohort Study of 5458 Patients. Annals of Gastroenterological Surgery, Article ags3.70280. https://doi.org/10.1002/ags3.70280

Image Credits: AI Generated

DOI: 10.1002/ags3.70280

Keywords: colorectal cancer, laparoscopic surgery, small bowel obstruction, adhesions, adhesion prevention materials, stoma, open surgery, nationwide cohort study, surgical outcomes, Seprafilm, rectal cancer, postoperative complications